Prostatype Genomics AB (publ) (PROGEN.ST)
SEK 1.85
(-1.86%)
SEK 1.85
(-1.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.35 Million | 682.79 Thousand | 10 Thousand | 683.87 Thousand | 74.08 Thousand | 161.84 Thousand |
| Cost of Revenue | 19.44 Million | 25.78 Million | -2.49 Million | 14.88 Million | -3.23 Million | -4.66 Million |
| Gross Profit | -18.09 Million | -25.09 Million | 2.5 Million | -14.2 Million | 3.3 Million | 4.82 Million |
| Operating Expenses | 3.22 Million | 29.37 Million | 18.05 Million | 2.41 Million | 11.17 Million | 13.98 Million |
| Selling, General and Administrative Expenses | 18.48 Million | 13.48 Million | 8.49 Million | 5.94 Million | 5.1 Million | 6.48 Million |
| Research and Development Expenses | 3.22 Million | 3.5 Million | 1.48 Million | 2.41 Million | 1.24 Million | 2.52 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 40.66 Million | 29.37 Million | 15.55 Million | 17.3 Million | 7.93 Million | 9.32 Million |
| Operating Income | -39.3 Million | -28.69 Million | -15.54 Million | -16.61 Million | -7.86 Million | -9.16 Million |
| Interest Expense | 1.54 Million | 396.24 Thousand | 81.49 Thousand | 1.49 Million | 684.24 Thousand | 156.9 Thousand |
| Income Tax Expense | - | 1.67 Million | -148.07 Thousand | -2.00 | -6998.00 | 3077.00 |
| Earnings before Tax | -41.43 Million | -29.08 Million | -15.62 Million | -17.4 Million | -8.54 Million | -9.31 Million |
| Net Income | -41.43 Million | -29.08 Million | -15.62 Million | -17.4 Million | -8.54 Million | -9.31 Million |
| Earnings Per Share Basic | -0.24 | -0.33 | -0.23 | -0.25 | -0.31 | -0.33 |
| Earnings Per Share Diluted | -0.24 | -0.33 | -0.23 | -0.25 | -0.31 | -0.33 |
| Weighted Average Shares Outstanding | 172.06 Million | 88.44 Million | 68.98 Million | 69.02 Million | 27.97 Million | 27.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 172.06 Million | 88.44 Million | 68.98 Million | 69.02 Million | 27.97 Million | 27.97 Million |
| Gross Margin | -13.34 | -36.76 | 250.94 | -20.77 | 44.66 | 29.80 |
| EBIT Margin | -28.04 | -39.23 | -1545.82 | -24.08 | -104.04 | -55.40 |
| Profit Margin | -30.56 | -42.60 | -1562.82 | -25.46 | -115.35 | -57.57 |
| EBITDA | -38.02 Million | -26.78 Million | -15.45 Million | -15.76 Million | -7.7 Million | -8.96 Million |
| Earnings Before Tax Margin | -28.99 | -42.02 | -1554.67 | -24.30 | -106.12 | -56.62 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 724 Thousand | 724 Thousand | 1.64 Million | 1.35 Million | 1.64 Million | 55.68 Thousand |
| Cost of Revenue | 5.4 Million | 5.4 Million | 5.53 Million | 37.43 Million | 5.53 Million | 8.57 Million |
| Gross Profit | -4.68 Million | -4.68 Million | -3.89 Million | -36.08 Million | -3.89 Million | -8.51 Million |
| Operating Expenses | 4.73 Million | 4.73 Million | 7.12 Million | 3.22 Million | 7.12 Million | 10.11 Million |
| Selling, General and Administrative Expenses | 3.94 Million | 3.94 Million | 5.78 Million | - | 5.78 Million | 3.63 Million |
| Research and Development Expenses | 490 Thousand | 490 Thousand | 586.87 Thousand | - | 586.87 Thousand | 1.52 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 10.14 Million | 10.14 Million | 12.66 Million | 40.66 Million | 12.66 Million | 10.11 Million |
| Operating Income | -9.7 Million | -9.7 Million | -10.69 Million | -39.3 Million | -10.69 Million | -10.05 Million |
| Interest Expense | - | - | - | 1.54 Million | - | 28 Thousand |
| Income Tax Expense | - | - | - | 1.7 Million | - | 45.00 |
| Earnings before Tax | -9.83 Million | -9.83 Million | -11.77 Million | -41.43 Million | -11.77 Million | -10.08 Million |
| Net Income | -9.83 Million | -9.83 Million | -11.77 Million | -41.43 Million | -11.77 Million | -10.08 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.13 | - | -0.13 | -0.09 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.13 | - | -0.13 | -0.09 |
| Weighted Average Shares Outstanding | 632.88 Million | 632.88 Million | 90.4 Million | 80.82 Million | 90.4 Million | 110.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 632.85 Million | 632.85 Million | 90.4 Million | 80.82 Million | 90.4 Million | 110.4 Million |
| Gross Margin | -6.47 | -6.47 | -2.37 | -26.61 | -2.37 | -153.00 |
| EBIT Margin | -13.39 | -13.39 | -6.24 | - | -6.24 | -172.18 |
| Profit Margin | -13.58 | -13.58 | -7.18 | -30.56 | -7.18 | -181.11 |
| EBITDA | -9.69 Million | -9.69 Million | -10.23 Million | - | -10.23 Million | -9.58 Million |
| Earnings Before Tax Margin | -13.40 | -13.40 | -6.52 | -28.99 | -6.52 | -180.61 |
NDO
UCIX
SYBLY
ORIN
ARESF
MNIF